InnoCan Pharma had a revenue of 6.82M in the quarter ending Sep 30, 2025, with -2.63%. This bring the company's revenue in the last twelve months to 27.02M, Increased -6.25%. In the fiscal year ending Mar 31, 2025, InnoCan Pharma had annual revenue of 29.44M with 115.55% growth.